Cannara Biotech (LOVFF) Earnings Dates, Call Summary & Reports

11 Followers

Earnings Data

Report Date

Jul 14, 2026

Before Open (Confirmed)

Period Ending

2026 (Q3)

Consensus EPS Forecast

0.04

Last Year’s EPS

0.03

Same Quarter Last Year

Analyst Consensus

Strong Buy

Based on 3 Analysts Ratings

Earnings Call Summary

Q2 2025

Earnings Call Date:Apr 28, 2025|

% Change Since:

Earnings Call Sentiment|Positive

The earnings call reflects a strong financial performance with record-breaking metrics and significant market share growth in key regions and product categories. However, there are challenges in maintaining market share in certain regions and managing cash flow effectively.

Company Guidance

During Cannara Biotech's Fiscal Year Q2 2025 earnings call, the company highlighted significant achievements and provided guidance for the future. Cannara reported record net revenues of CAD 26.6 million, marking a 6% increase quarter-over-quarter and a 35% rise year-over-year. The company also achieved a record gross profit before fair value adjustments of CAD 10.8 million, with a gross margin of 41%. Adjusted EBITDA was CAD 7.1 million, representing an 18% increase quarter-over-quarter and over 100% year-over-year growth, with an adjusted EBITDA margin of 27%. Cannara holds a 12.8% market share in Quebec, up from 9% the previous year, and is now the fastest-growing licensed producer in Canada by market share. The company plans to expand its cultivation capacity by nearly 20% to address increasing demand, especially with the upcoming vape market launch in Quebec. Cannara aims to leverage its competitive advantages in premium quality, scalability, and cost leadership to further drive growth and maintain strong financial performance.

Record-Breaking Financial Performance

Cannara achieved record revenue, gross profit, gross margin, operating income, and adjusted EBITDA in Q2 2025. Net revenues were CAD 26.6 million, up 6% quarter-over-quarter and 35% year-over-year. Adjusted EBITDA was CAD 7.1 million, up 18% quarter-over-quarter, representing over 100% year-over-year growth.

Strong Market Position in Quebec

Cannara holds a 12.8% market share in Quebec, up over 40% from the previous year. They are only 60 basis points from the number one spot, showing significant market share growth in their home province.

Leadership in Product Categories

Cannara leads the nationwide premium vape category with over 22% share and is the fastest-growing infused pre-roll multi-pack in Canada with a 10% market share. They have a commanding 73% share of infused pre-rolls in Quebec.

Cost Leadership and Operational Efficiency

Cannara maintains one of the lowest electricity rates in Canada, enabling cost-effective operations. They are expanding cultivation capacity by 20% with minimal capital outlay, showcasing strong operational efficiency.

Cannara Biotech (LOVFF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LOVFF Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jul 14, 2026	2026 (Q3)	0.04 / -	0.028	―	―	―
Apr 14, 2026	2026 (Q2)	0.04 / 0.01	0.026	-45.95% (-0.01)	―
Jan 26, 2026	2026 (Q1)	- / <0.01	0.018	-61.54% (-0.01)
Nov 24, 2025	2025 (Q4)	- / 0.03	0.045	-37.50% (-0.02)
Jul 28, 2025	2025 (Q3)	- / 0.03	0.015	81.82% (+0.01)	―
Apr 28, 2025	2025 (Q2)	- / 0.03	-0.027	197.37% (+0.05)
Jan 27, 2025	2025 (Q1)	- / 0.02	0.016	13.04% (<+0.01)	―	―
Nov 25, 2024	2024 (Q4)	- / 0.04	0.036	25.49% (<+0.01)	―	―
Jul 23, 2024	2024 (Q3)	- / 0.02	0.023	-33.33% (>-0.01)	―	―
Apr 29, 2024	2024 (Q2)	- / -0.03	-0.005	-442.86% (-0.02)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LOVFF Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Apr 14, 2026	$1.44	$1.39	-3.46%
Jan 26, 2026	$1.41	$1.39	-1.21%
Nov 24, 2025	$1.21	$1.30	+7.52%
Jul 28, 2025	$1.30	$1.32	+1.53%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cannara Biotech (LOVFF) report earnings?

Cannara Biotech (LOVFF) is schdueled to report earning on Jul 14, 2026, Before Open (Confirmed).

What is Cannara Biotech (LOVFF) earnings time?

Cannara Biotech (LOVFF) earnings time is at Jul 14, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LOVFF EPS forecast?

LOVFF EPS forecast for the fiscal quarter 2026 (Q3) is 0.04.